It is consistent with previous reports showing that DNCB treatment specifically increases IL-6 secretion in HaCaT cells as well as the transcription of TNF-α, IL-6, and IL-8 in primary KCs [52,53]. The gene discussed is CXCL8; the disease is dry eye syndrome.